Pfizer-BioNTech Shot Likely Beats New Covid Strain, EMA Says

The new strain of Covid-19 that emerged in the U.K. probably isn’t different enough from earlier ones to elude Pfizer Inc. and BioNTech SE’s vaccine, Europe’s health regulator said.

The antibody response seen from the shot shouldn’t be compromised by the effects of mutations in the new strain, Marco Cavaleri, chairman of the European Medicines Agency’s pandemic taskforce, said in a press briefing on Monday. Health authorities would start to be worried “if we see multiple mutations, particularly in the spike protein,” Cavaleri said.